Accelerated phosphatidylcholine turnover in macrophages promotes adipose tissue inflammation in obesity. 2019

Kasparas Petkevicius, and Sam Virtue, and Guillaume Bidault, and Benjamin Jenkins, and Cankut Çubuk, and Cecilia Morgantini, and Myriam Aouadi, and Joaquin Dopazo, and Mireille J Serlie, and Albert Koulman, and Antonio Vidal-Puig
University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, MDU MRC, Cambridge, United Kingdom.

White adipose tissue (WAT) inflammation contributes to the development of insulin resistance in obesity. While the role of adipose tissue macrophage (ATM) pro-inflammatory signalling in the development of insulin resistance has been established, it is less clear how WAT inflammation is initiated. Here, we show that ATMs isolated from obese mice and humans exhibit markers of increased rate of de novo phosphatidylcholine (PC) biosynthesis. Macrophage-specific knockout of phosphocholine cytidylyltransferase A (CCTα), the rate-limiting enzyme of de novo PC biosynthesis pathway, alleviated obesity-induced WAT inflammation and insulin resistance. Mechanistically, CCTα-deficient macrophages showed reduced ER stress and inflammation in response to palmitate. Surprisingly, this was not due to lower exogenous palmitate incorporation into cellular PCs. Instead, CCTα-null macrophages had lower membrane PC turnover, leading to elevated membrane polyunsaturated fatty acid levels that negated the pro-inflammatory effects of palmitate. Our results reveal a causal link between obesity-associated increase in de novo PC synthesis, accelerated PC turnover and pro-inflammatory activation of ATMs.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D007333 Insulin Resistance Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. Insulin Sensitivity,Resistance, Insulin,Sensitivity, Insulin
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008820 Mice, Obese Mutant mice exhibiting a marked obesity coupled with overeating, hyperglycemia, hyperinsulinemia, marked insulin resistance, and infertility when in a homozygous state. They may be inbred or hybrid. Hyperglycemic Mice,Obese Mice,Mouse, Hyperglycemic,Mouse, Obese,Hyperglycemic Mouse,Mice, Hyperglycemic,Obese Mouse
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010713 Phosphatidylcholines Derivatives of PHOSPHATIDIC ACIDS in which the phosphoric acid is bound in ester linkage to a CHOLINE moiety. Choline Phosphoglycerides,Choline Glycerophospholipids,Phosphatidyl Choline,Phosphatidyl Cholines,Phosphatidylcholine,Choline, Phosphatidyl,Cholines, Phosphatidyl,Glycerophospholipids, Choline,Phosphoglycerides, Choline
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000273 Adipose Tissue Specialized connective tissue composed of fat cells (ADIPOCYTES). It is the site of stored FATS, usually in the form of TRIGLYCERIDES. In mammals, there are two types of adipose tissue, the WHITE FAT and the BROWN FAT. Their relative distributions vary in different species with most adipose tissue being white. Fatty Tissue,Body Fat,Fat Pad,Fat Pads,Pad, Fat,Pads, Fat,Tissue, Adipose,Tissue, Fatty
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Kasparas Petkevicius, and Sam Virtue, and Guillaume Bidault, and Benjamin Jenkins, and Cankut Çubuk, and Cecilia Morgantini, and Myriam Aouadi, and Joaquin Dopazo, and Mireille J Serlie, and Albert Koulman, and Antonio Vidal-Puig
December 2023, Proceedings of the National Academy of Sciences of the United States of America,
Kasparas Petkevicius, and Sam Virtue, and Guillaume Bidault, and Benjamin Jenkins, and Cankut Çubuk, and Cecilia Morgantini, and Myriam Aouadi, and Joaquin Dopazo, and Mireille J Serlie, and Albert Koulman, and Antonio Vidal-Puig
January 2007, Gaceta medica de Mexico,
Kasparas Petkevicius, and Sam Virtue, and Guillaume Bidault, and Benjamin Jenkins, and Cankut Çubuk, and Cecilia Morgantini, and Myriam Aouadi, and Joaquin Dopazo, and Mireille J Serlie, and Albert Koulman, and Antonio Vidal-Puig
June 2012, Radiology,
Kasparas Petkevicius, and Sam Virtue, and Guillaume Bidault, and Benjamin Jenkins, and Cankut Çubuk, and Cecilia Morgantini, and Myriam Aouadi, and Joaquin Dopazo, and Mireille J Serlie, and Albert Koulman, and Antonio Vidal-Puig
March 2014, Diabetologia,
Kasparas Petkevicius, and Sam Virtue, and Guillaume Bidault, and Benjamin Jenkins, and Cankut Çubuk, and Cecilia Morgantini, and Myriam Aouadi, and Joaquin Dopazo, and Mireille J Serlie, and Albert Koulman, and Antonio Vidal-Puig
April 2018, Diabetologia,
Kasparas Petkevicius, and Sam Virtue, and Guillaume Bidault, and Benjamin Jenkins, and Cankut Çubuk, and Cecilia Morgantini, and Myriam Aouadi, and Joaquin Dopazo, and Mireille J Serlie, and Albert Koulman, and Antonio Vidal-Puig
January 2014, Cell metabolism,
Kasparas Petkevicius, and Sam Virtue, and Guillaume Bidault, and Benjamin Jenkins, and Cankut Çubuk, and Cecilia Morgantini, and Myriam Aouadi, and Joaquin Dopazo, and Mireille J Serlie, and Albert Koulman, and Antonio Vidal-Puig
January 2008, Current pharmaceutical design,
Kasparas Petkevicius, and Sam Virtue, and Guillaume Bidault, and Benjamin Jenkins, and Cankut Çubuk, and Cecilia Morgantini, and Myriam Aouadi, and Joaquin Dopazo, and Mireille J Serlie, and Albert Koulman, and Antonio Vidal-Puig
August 2022, Nature communications,
Kasparas Petkevicius, and Sam Virtue, and Guillaume Bidault, and Benjamin Jenkins, and Cankut Çubuk, and Cecilia Morgantini, and Myriam Aouadi, and Joaquin Dopazo, and Mireille J Serlie, and Albert Koulman, and Antonio Vidal-Puig
December 2022, Molecular metabolism,
Kasparas Petkevicius, and Sam Virtue, and Guillaume Bidault, and Benjamin Jenkins, and Cankut Çubuk, and Cecilia Morgantini, and Myriam Aouadi, and Joaquin Dopazo, and Mireille J Serlie, and Albert Koulman, and Antonio Vidal-Puig
April 2015, Diabetes,
Copied contents to your clipboard!